Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Home » News » Renal Transplant programs have record year

Renal Transplant programs have record year

Winnipeg Regional Health Authority
Published Tuesday, January 31, 2017

A record 57 Manitobans, including six youth, received kidney transplants through Manitoba's Renal Transplant Programs in 2016.

Kidney disease is a growing problem and people living with it experience a reduced quality of life and risk premature death.

"Kidney transplantation is often the best treatment for people living with kidney disease," says Dr. Peter Nickerson, Medical Director, Transplant Manitoba - Gift of Life. "A transplant means living a longer, healthier, active life without being tied to the demands of dialysis."

Twenty-five of those gifts came from living kidney donors and another six came from three donors via Manitoba's latest donation option: donation after cardiac death (DCD).

"Manitobans have access to some of the best kidney care and transplantation services in the country," says Kelvin Goertzen, Minister of Health, Seniors and Active Living. "This is the first full year Manitobans have had the opportunity to consider DCD and we are so pleased to be able to give more families the option of choosing organ donation."

Adults weren't the only recipients of donated kidneys. Six children were recipients, allowing them the opportunity to fulfill their potential, according to Dr. Patricia Birk, Medical Director of the Pediatric Renal Transplant program.

"Dialysis is a great hardship on the kids and on the family. They're going back and forth to the dialysis unit three or four times a week, they're on multiple medications and they have a lot of dietary restrictions. It is a real burden."

Since 1969, over 1,500 kidney transplants have been performed by the adult program and the pediatric program combined. Led by Dr. David Rush and Birk, both programs were the first to introduce surveillance biopsy programs that have led to their adoption in many countries worldwide, and established Winnipeg as a centre of excellence in translational research.

"In over 30 years of caring for patients and being part of the changes in the field of transplantation, it is very rewarding to know we have been able to improve outcomes for kidney recipients and give them a better opportunity to live life to the fullest," says Rush, Medical Director of the Adult Renal Transplant Program.

In addition to Rush's innovations, 2016 saw national and international honours and recognition for Nickerson and Dr. Julie Ho.

Nickerson earned an AST Clinical Scientist Established Investigator award for his work in leading the Canadian national standardization of HLA laboratory practice and the development of an interprovincial transplant network in Canada that has had an impact on the lives of hundreds of Canadians.

Nickerson, who is also Vice-Dean (Research) and Distinguished Professor, Flynn Family Chair in Renal Transplantation, Rady Faculty of Health Sciences, University of Manitoba, performs research on the genetic and immunologic basis of organ rejection and has created new paradigms for transplantation.

He was also awarded the ASHI Paul Terasaki award to acknowledge the success of his team in identifying the role of HLA antibodies in causing premature kidney transplant loss and developing novel strategies to prevent antibody development.

Ho, who is a transplant physician at Transplant Manitoba and assistant professor of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, earned a $2.6 million Canadian Institutes of Health Research project grant to support a first-of-its-kind clinical trial.

Ho and her team have identified a new urine test to detect rejection and predict outcomes in kidney transplantation; meaning patients at high-risk of losing their transplants may be identified sooner. Ho will study the impact of an early rejection marker on transplant outcomes with the goal of having new urine tests that could be used to personalize medicine and improve patient and transplant health.

Share this page

Skip to content